100A
100A invests in fintech companies and funds across Europe and the US, with a focus on B2B fintech and financial infrastructure.
13books Capital

13books Capital invests in financial technology companies and partners with fintech founders seeking to scale globally.
20VC

20VC operates at the intersection of venture capital and media, focusing on AI, infrastructure, and tech-driven innovation. The firm provides insights, analysis, and content to highlight trends in AI, venture capital, and tech industries, emphasizing high-growth markets and disruptive technologies.
24 Haymarket

24Haymarket is a micro growth-equity firm investing in high-growth technology companies across the UK.
3i Group

3i Group is an investment company specializing in private equity and infrastructure, investing in mid-market companies headquartered in Europe and North America.
4BIO Capital

4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector. Their objective is to invest in, support, and grow early-stage companies developing treatments in areas of high unmet medical need. The firm aims to ensure access to these potentially curative therapies for all patients. They target viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The firm offers investors undiluted access to the fastest-growing field of medicine, and to companies, they provide the capital and expert guidance needed to succeed. 4BIO believes in a future where advanced therapies are the standard of care, and they are passionate about using the knowledge and experience of its team to help address the challenge of chronic disease. The team aims to identify companies that are likely to have a real impact on patients' lives. 4BIO's team comprises leading advanced therapy scientists and experienced life science investors. The team members have published over 250 scientific articles in prestigious academic journals, including Nature, The Lancet, Cell, and the New England Journal of Medicine. This deep scientific and investment expertise provides 4BIO with an unrivaled network within the advanced therapy sector and a unique understanding of the criteria that separate the very best investment opportunities. In-depth understanding is the key to success in the rapidly developing therapeutic landscape.
9900 Capital

Based on the available information, BNVT Capital is a venture capital firm that focuses on investing in startups tackling significant societal problems. The firm launched a $150 million debut fund aimed at supporting companies that address these challenges. They seem to be particularly interested in startups and scale-ups. They invest in companies that align with specific impact goals, and focus on specific technology areas to tackle these big challenges.
ALSA Ventures
ALSA Ventures is a London-based international life-sciences investor focused on novel therapeutics across the drug-development spectrum.
AP Ventures

AP Ventures invests in high-growth technology companies addressing pain points in the hydrogen value chain and broader industrial sectors, focusing on operational performance, resilience, and lower-carbon transitions. The firm leverages expertise in chemistry, materials science, and engineering to support founders in scaling technically complex solutions for energy-intensive industries.
AVIVA Impact Investing

Aviva Investors is a global asset management business of Aviva plc, delivering investment management solutions, services, and client-driven performance to clients worldwide. Their approach is rooted in collaboration, responsible action, and commitment, aiming to design solutions that last. The firm focuses on both public and private markets, offering a range of investment strategies and capabilities tailored for institutional and intermediary investors. Aviva Investors is committed to innovation and technological advancements that can bring positive change, as evidenced by their recent efforts to tokenise traditional fund structures. They are also focused on expanding their reach and impact through strategic investments in key sectors like renewable energy and real estate, as well as strengthening client relationships and distribution capabilities across different geographies. Aviva Investors is actively investing in climate transition strategies, seeking opportunities in core energy markets and new technologies that help industries prepare for the future. A key example is their investment in Terra One Climate Solutions to support the development of battery energy storage systems (BESS) in Germany. This investment reflects their broader strategy of increasing exposure to the renewable energy sector while capturing growth and returns. Additionally, their real estate investments, such as the acquisition of New Broad Street House, align with the strategic priorities of cities like London, aiming to deliver additional office floorspace and unlock development potential. The firm's investment strategy also emphasizes the importance of client service and relationship management, particularly with institutional investors and consultants. They aim to understand the needs of these investors and provide support in navigating market challenges to reach their long-term investment objectives. The appointment of key personnel, such as Heads of EMEA Institutional Client Relationship Management and Global Consultant Relations, underscores their commitment to strengthening these relationships and driving business growth. Aviva Investors also demonstrates a forward-thinking approach by exploring tokenization of fund structures to enhance time and cost efficiency for investors.
Ada Ventures

Ada Ventures backs European founders building businesses for a better human future, focusing on inclusive pre-seed investing in technology companies across climate equity, economic empowerment, and healthy ageing.
Additio Investment Group
Additio Investment Group is an investment syndicate focused on seed and Series A companies in healthcare and life sciences.
Adoreum Partners
Adoreum invests in founders and teams that embody the 'chemistry of connection,' fostering exhilaration, inspiration, and collaboration. The firm seeks to empower entrepreneurs in sectors where human-centric innovation drives meaningful impact, such as technology, consumer, healthcare, finance, and social impact.
Advance Global Capital

Advance Global Capital (AGC) specializes in bridging the financing gap for SMEs in underserved markets by partnering with local non-bank financial institutions (NBFIs). Their approach leverages receivables financing to unlock liquidity for businesses, prioritizing women-led and underrepresented groups. AGC aligns with UN Sustainability Goals (5, 8, 9, 10) to drive responsible social impact and economic resilience through strategic capital deployment.
Advent Life Sciences

Advent Life Sciences is a venture-capital firm that invests in and supports companies translating breakthrough science into healthcare products.
Agronomics

Agronomics invests in companies developing new ways to produce food with fewer resources and less waste. Its portfolio spans cellular agriculture and other biomanufacturing technologies such as cell culture and precision fermentation.
Ahren Capital

Focuses on securing strategic-grade domain names for established businesses and funded startups to align with long-term brand strategy, reducing operational friction and enhancing growth.
Alba Equity
Alba Equity is a Scottish investment syndicate that backs businesses at seed and early stages.
Amadeus APEX Technology Fund

Amadeus Capital Partners focuses on deep tech investments across three core areas: Intelligence (AI, advanced computing, and quantum), Human (health, medicine, and wellness), and Planet (sustainability, energy, novel materials, and space utilization). The firm targets companies with transformative technological potential, backing them from early-stage seed funding through growth phases.
Amberside Advisors

Amberside Capital focuses on sustainable infrastructure, energy transition, and protected agriculture, helping companies raise capital and supporting funds in investments across these sectors. Their expertise includes fibre networks, decarbonisation, electrification, and domestic food production.
Ananda Impact Venture

Decoding musculoskeletal disease with proprietary technology and machine learning to uncover transformative therapies in an area of unmet medical need.
Angel Academe

Angel Academe is a mainly female angel network and EIS fund that invests in female-founded startups and seeks to improve gender diversity in startup investment.
Angel CoFund (ACF)

The Angel CoFund is a £100M venture capital fund that partners with sector-focused angel investors to provide meaningful capital (minimum £40k per round for Angel CoFund, £70k for Delta Fund) and support for UK entrepreneurs. It emphasizes alignment of interests, capital growth, and due diligence by syndicates of experienced angels.
Angel Investment Network

Angel Investment Network (AIN) supports early-stage startups by connecting founders with a global network of angel investors. They emphasize capital efficiency, founder education, and backing diverse founders, particularly women and underrepresented groups. AIN also provides resources and insights to help startups navigate fundraising and equity protection.